Insider Trading & Ownership of David Mott

Location: Baltimore, MD
Summary: The estimated net worth of David Mott is at least $23,458,642 dollars as of 23 Feb 2026. David Mott is the Director of ARDELYX, INC. and owns shares of ARDELYX, INC. (ARDX) stock worth about $19.29M. David Mott is the Director of IMARA Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $3.47M. David Mott is the Director of NOVAVAX INC and owns shares of NOVAVAX INC (NVAX) stock worth about $703.6K.
Signature: /s/ Elizabeth Grammer, Attorney-in-Fact for David Mott
All Insider Reports: All Insider Reports

Notify me when David Mott files a new Insider Trading report.

Ownership of David Mott

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
ARDX	ARDELYX, INC.	Director	$19,285,738	+$5,349,528	+38%	20 Feb 2026
ELVN	IMARA Inc.	Director	$3,469,305			02 Jun 2022
NVAX	NOVAVAX INC	Director	$703,599			20 Jun 2025
MRSN	Mersana Therapeutics, Inc.	Director	$0			06 Jan 2026
ADAPY	Adaptimmune Therapeutics PLC	Director				01 Jul 2024
EPZM	Epizyme, Inc.	Director				12 Aug 2022

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.